Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 147

1.

Cost-effectiveness of Ambulatory Oxygen in improving quality of life in fibrotic lung disease: Preliminary evidence from the AmbOx Trial.

Whitty JA, Rankin J, Visca D, Tsipouri V, Mori L, Spencer L, Adamali H, Maher TM, Hopkinson NS, Birring SS, Farquhar M, Wells AU, Sestini P, Renzoni EA.

Eur Respir J. 2019 Nov 7. pii: 1901157. doi: 10.1183/13993003.01157-2019. [Epub ahead of print] No abstract available.

PMID:
31699838
2.

Cough presentation in primary care and the identification of chronic cough: a need for diagnostic clarity?

Holden SE, Morice A, Birring SS, Jenkins-Jones S, Langerman H, Weaver J, Currie CJ.

Curr Med Res Opin. 2019 Oct 10:1-12. doi: 10.1080/03007995.2019.1673716. [Epub ahead of print]

PMID:
31558053
3.

Clinical Characteristics of Cough Frequency Patterns in Patients with and without Asthma.

Fukuhara A, Saito J, Birring SS, Sato S, Uematsu M, Suzuki Y, Rikimaru M, Watanabe N, Saito M, Kawamata T, Umeda T, Togawa R, Sato Y, Koizumi T, Hirai K, Minemura H, Nikaido T, Kanazawa K, Tanino Y, Munakata M, Shibata Y.

J Allergy Clin Immunol Pract. 2019 Sep 18. pii: S2213-2198(19)30784-6. doi: 10.1016/j.jaip.2019.08.053. [Epub ahead of print]

PMID:
31541769
4.

ERS guidelines on the diagnosis and treatment of chronic cough in adults and children.

Morice AH, Millqvist E, Bieksiene K, Birring SS, Dicpinigaitis P, Ribas CD, Boon MH, Kantar A, Lai K, McGarvey L, Rigau D, Satia I, Smith J, Song WJ, Tonia T, van den Berg JWK, van Manen MJG, Zacharasiewicz A.

Eur Respir J. 2019 Sep 12. pii: 1901136. doi: 10.1183/13993003.01136-2019. [Epub ahead of print]

PMID:
31515408
5.

Impact of Cough and Unmet Needs in Chronic Cough: A Survey of Patients in Korea.

Kang SY, Won HK, Lee SM, Kwon JW, Kim MH, Jo EJ, Lee SE, Kim SH, Chang YS, Lee SP, Lee BJ, Cho SH, Birring SS, Song WJ.

Lung. 2019 Oct;197(5):635-639. doi: 10.1007/s00408-019-00258-9. Epub 2019 Aug 16.

PMID:
31418078
6.

Cough-Related Laryngeal Sensations and Triggers in Adults With Chronic Cough: Symptom Profile and Impact.

Won HK, Kang SY, Kang Y, An J, Lee JH, Lee SM, Kwon JW, Kim MH, Jo EJ, Lee SE, Kim SH, Kim SH, Chang YS, Kim SH, Lee BJ, Cho SH, Birring SS, Song WJ.

Allergy Asthma Immunol Res. 2019 Sep;11(5):622-631. doi: 10.4168/aair.2019.11.5.622.

7.

King's Brief Interstitial Lung Disease questionnaire: responsiveness and minimum clinically important difference.

Nolan CM, Birring SS, Maddocks M, Maher TM, Patel S, Barker RE, Jones SE, Walsh JA, Wynne SC, George PM, Man WD.

Eur Respir J. 2019 Sep 5;54(3). pii: 1900281. doi: 10.1183/13993003.00281-2019. Print 2019 Sep.

PMID:
31221807
8.

Chronic cough: ATP, afferent pathways and hypersensitivity.

Turner RD, Birring SS.

Eur Respir J. 2019 Jul 4;54(1). pii: 1900889. doi: 10.1183/13993003.00889-2019. Print 2019 Jul. No abstract available.

PMID:
31164438
9.

New understanding in the treatment of cough (NEUROCOUGH) ERS Clinical Research Collaboration: improving care and treatment for patients with cough.

McGarvey L, Dupont L, Birring SS, Boyd J, Chung KF, Dabrowska M, Domingo C, Fontana G, Guilleminault L, Kardos P, Millqvist E, Morice AH, Smith JA, van den Berg JW, Van de Kerkhove C; NEUROCOUGH Clinical Research Collaboration.

Eur Respir J. 2019 May 30;53(5). pii: 1900787. doi: 10.1183/13993003.00787-2019. Print 2019 May. No abstract available.

PMID:
31147424
10.

Translation and psychometric properties of the King's Sarcoidosis Questionnaire (KSQ) in German language.

Farin E, Heyduck K, Frye BC, Birring SS, Müller-Quernheim J, Schupp JC.

Health Qual Life Outcomes. 2019 Apr 11;17(1):62. doi: 10.1186/s12955-019-1131-z.

11.

The King's Brief Interstitial Lung Disease (KBILD) questionnaire: an updated minimal clinically important difference.

Sinha A, Patel AS, Siegert RJ, Bajwah S, Maher TM, Renzoni EA, Wells AU, Higginson IJ, Birring SS.

BMJ Open Respir Res. 2019 Feb 18;6(1):e000363. doi: 10.1136/bmjresp-2018-000363. eCollection 2019.

12.

The Effect of Aclidinium on Symptoms Including Cough in Chronic Obstructive Pulmonary Disease: A Phase 4, Double-Blind, Placebo-controlled, Parallel-Group Study.

Smith JA, McGarvey L, Morice AH, Birring SS, Wedzicha JA, Notari M, Zapata A, Segarra R, Seoane B, Jarreta D.

Am J Respir Crit Care Med. 2019 Sep 1;200(5):642-645. doi: 10.1164/rccm.201901-0048LE. No abstract available.

13.

Idiopathic pulmonary fibrosis-associated cough: Mechanisms and management.

Myall KJ, Kavanagh JE, Birring SS.

Pulm Pharmacol Ther. 2019 Jun;56:100-103. doi: 10.1016/j.pupt.2019.03.008. Epub 2019 Mar 28. Review. No abstract available.

PMID:
30930174
14.

Methods of Cough Assessment.

Cho PSP, Birring SS, Fletcher HV, Turner RD.

J Allergy Clin Immunol Pract. 2019 Jul - Aug;7(6):1715-1723. doi: 10.1016/j.jaip.2019.01.049. Epub 2019 Mar 27. Review.

PMID:
30928483
15.

Physical Inactivity in Pulmonary Sarcoidosis.

Cho PSP, Vasudevan S, Maddocks M, Spinou A, Chamberlain Mitchell S, Wood C, Jolley CJ, Birring SS.

Lung. 2019 Jun;197(3):285-293. doi: 10.1007/s00408-019-00215-6. Epub 2019 Mar 19.

16.

Antitussive therapy: A role for levodropropizine.

Birring S, de Blasio F, Dicpinigaitis PV, Fontana G, Lanata L, Page C, Saibene F, Zanasi A.

Pulm Pharmacol Ther. 2019 Jun;56:79-85. doi: 10.1016/j.pupt.2019.03.003. Epub 2019 Mar 11. Review.

PMID:
30872161
17.

Impaired cough suppression in chronic refractory cough.

Cho PSP, Fletcher HV, Turner RD, Jolley CJ, Birring SS.

Eur Respir J. 2019 May 2;53(5). pii: 1802203. doi: 10.1183/13993003.02203-2018. Print 2019 May.

PMID:
30819813
18.

Non-pharmacological interventions for chronic cough: The past, present and future.

Chamberlain Mitchell SAF, Ellis J, Ludlow S, Pandyan A, Birring SS.

Pulm Pharmacol Ther. 2019 Jun;56:29-38. doi: 10.1016/j.pupt.2019.02.006. Epub 2019 Feb 23. Review.

PMID:
30807836
19.

Psychometric properties of the German version of the Leicester Cough Questionnaire in sarcoidosis.

Schupp JC, Fichtner UA, Frye BC, Heyduck-Weides K, Birring SS, Windisch W, Criée CP, Müller-Quernheim J, Farin E.

PLoS One. 2018 Oct 4;13(10):e0205308. doi: 10.1371/journal.pone.0205308. eCollection 2018.

20.

Effect of ambulatory oxygen on quality of life for patients with fibrotic lung disease (AmbOx): a prospective, open-label, mixed-method, crossover randomised controlled trial.

Visca D, Mori L, Tsipouri V, Fleming S, Firouzi A, Bonini M, Pavitt MJ, Alfieri V, Canu S, Bonifazi M, Boccabella C, De Lauretis A, Stock CJW, Saunders P, Montgomery A, Hogben C, Stockford A, Pittet M, Brown J, Chua F, George PM, Molyneaux PL, Margaritopoulos GA, Kokosi M, Kouranos V, Russell AM, Birring SS, Chetta A, Maher TM, Cullinan P, Hopkinson NS, Banya W, Whitty JA, Adamali H, Spencer LG, Farquhar M, Sestini P, Wells AU, Renzoni EA.

Lancet Respir Med. 2018 Oct;6(10):759-770. doi: 10.1016/S2213-2600(18)30289-3. Epub 2018 Aug 28.

21.

Treatment of Interstitial Lung Disease Associated Cough: CHEST Guideline and Expert Panel Report.

Birring SS, Kavanagh JE, Irwin RS, Keogh KA, Lim KG, Ryu JH; Collaborators.

Chest. 2018 Oct;154(4):904-917. doi: 10.1016/j.chest.2018.06.038. Epub 2018 Jul 20.

PMID:
30036496
22.

Daily cough frequency in tuberculosis and association with household infection.

Turner RD, Birring SS, Darmalingam M, Hooper RL, Kunst H, Matos S, Bothamley GH.

Int J Tuberc Lung Dis. 2018 Aug 1;22(8):863-870. doi: 10.5588/ijtld.17.0652.

PMID:
29991394
23.

Clinical features of sarcoidosis associated pulmonary hypertension: Results of a multi-national registry.

Baughman RP, Shlobin OA, Wells AU, Alhamad EH, Culver DA, Barney J, Cordova FC, Carmona EM, Scholand MB, Wijsenbeek M, Ganesh S, Birring SS, Kouranos V, O'Hare L, Baran JM, Cal JG, Lower EE, Engel PJ, Nathan SD.

Respir Med. 2018 Jun;139:72-78. doi: 10.1016/j.rmed.2018.04.015. Epub 2018 May 5.

PMID:
29858005
24.

Quality of life assessment in interstitial lung diseases:a comparison of the disease-specific K-BILD with the generic EQ-5D-5L.

Szentes BL, Kreuter M, Bahmer T, Birring SS, Claussen M, Waelscher J, Leidl R, Schwarzkopf L.

Respir Res. 2018 May 25;19(1):101. doi: 10.1186/s12931-018-0808-x.

25.

An update and systematic review on drug therapies for the treatment of refractory chronic cough.

Ryan NM, Vertigan AE, Birring SS.

Expert Opin Pharmacother. 2018 May;19(7):687-711. doi: 10.1080/14656566.2018.1462795. Epub 2018 Apr 16. Review.

26.

Best supportive care for idiopathic pulmonary fibrosis: current gaps and future directions.

Ferrara G, Luppi F, Birring SS, Cerri S, Caminati A, Sköld M, Kreuter M.

Eur Respir Rev. 2018 Feb 7;27(147). pii: 170076. doi: 10.1183/16000617.0076-2017. Print 2018 Mar 31. Review.

27.

Pulmonary Sarcoidosis in a patient with Multiple Sclerosis on daclizumab monotherapy.

Rhone EE, Cho PSP, Birring SS, Galloway J, Silber E.

Mult Scler Relat Disord. 2018 Feb;20:25-27. doi: 10.1016/j.msard.2017.12.011. Epub 2017 Dec 18.

PMID:
29276998
28.

Effect of pirfenidone on cough in patients with idiopathic pulmonary fibrosis.

van Manen MJG, Birring SS, Vancheri C, Vindigni V, Renzoni E, Russell AM, Wapenaar M, Cottin V, Wijsenbeek MS.

Eur Respir J. 2017 Oct 19;50(4). pii: 1701157. doi: 10.1183/13993003.01157-2017. Print 2017 Oct. No abstract available.

29.

A review of the musculoskeletal manifestations of sarcoidosis.

Bechman K, Christidis D, Walsh S, Birring SS, Galloway J.

Rheumatology (Oxford). 2018 May 1;57(5):777-783. doi: 10.1093/rheumatology/kex317. Review.

PMID:
28968840
30.

New drug targets for chronic cough: research you can literally sink your teeth into!

Jolley CJ, Birring SS.

Eur Respir J. 2017 Sep 20;50(3). pii: 1701571. doi: 10.1183/13993003.01571-2017. Print 2017 Sep. No abstract available.

31.

A novel formulation of inhaled sodium cromoglicate (PA101) in idiopathic pulmonary fibrosis and chronic cough: a randomised, double-blind, proof-of-concept, phase 2 trial.

Birring SS, Wijsenbeek MS, Agrawal S, van den Berg JWK, Stone H, Maher TM, Tutuncu A, Morice AH.

Lancet Respir Med. 2017 Oct;5(10):806-815. doi: 10.1016/S2213-2600(17)30310-7. Epub 2017 Sep 8.

32.

Theobromine for the treatment of persistent cough: a randomised, multicentre, double-blind, placebo-controlled clinical trial.

Morice AH, McGarvey L, Pavord ID, Higgins B, Chung KF, Birring SS.

J Thorac Dis. 2017 Jul;9(7):1864-1872. doi: 10.21037/jtd.2017.06.18.

33.

Sound: a non-invasive measure of cough intensity.

Lee KK, Matos S, Ward K, Rafferty GF, Moxham J, Evans DH, Birring SS.

BMJ Open Respir Res. 2017 May 12;4(1):e000178. doi: 10.1136/bmjresp-2017-000178. eCollection 2017.

34.

The Objective Assessment of Cough Frequency in Bronchiectasis.

Spinou A, Lee KK, Sinha A, Elston C, Loebinger MR, Wilson R, Chung KF, Yousaf N, Pavord ID, Matos S, Garrod R, Birring SS.

Lung. 2017 Oct;195(5):575-585. doi: 10.1007/s00408-017-0038-x. Epub 2017 Jul 13.

35.

Minimal Clinically Important Differences (MCIDs) of the Thai Version of the Leicester Cough Questionnaire for Subacute and Chronic Cough.

Pornsuriyasak P, Thungtitigul P, Kawamatawong T, Birring SS, Pongmesa T.

Value Health Reg Issues. 2017 May;12:57-62. doi: 10.1016/j.vhri.2017.03.009. Epub 2017 May 4.

PMID:
28648317
36.

The development and validation of the Bronchiectasis Health Questionnaire.

Spinou A, Siegert RJ, Guan WJ, Patel AS, Gosker HR, Lee KK, Elston C, Loebinger MR, Wilson R, Garrod R, Birring SS.

Eur Respir J. 2017 May 11;49(5). pii: 1601532. doi: 10.1183/13993003.01532-2016. Print 2017 May.

37.

Physiotherapy and Speech and Language therapy intervention for chronic cough.

Birring SS, Floyd S, Reilly CC, Cho PSP.

Pulm Pharmacol Ther. 2017 Dec;47:84-87. doi: 10.1016/j.pupt.2017.04.001. Epub 2017 Apr 4. Review.

PMID:
28389257
38.

Repository corticotropin for Chronic Pulmonary Sarcoidosis.

Baughman RP, Sweiss N, Keijsers R, Birring SS, Shipley R, Saketkoo LA, Lower EE.

Lung. 2017 Jun;195(3):313-322. doi: 10.1007/s00408-017-9994-4. Epub 2017 Mar 28.

39.

The search for the hypersensitivity in chronic cough.

Birring SS.

Eur Respir J. 2017 Feb 8;49(2). pii: 1700082. doi: 10.1183/13993003.00082-2017. Print 2017 Feb. No abstract available.

40.

Rococo study: a real-world evaluation of an over-the-counter medicine in acute cough (a multicentre, randomised, controlled study).

Birring SS, Brew J, Kilbourn A, Edwards V, Wilson R, Morice AH.

BMJ Open. 2017 Jan 16;7(1):e014112. doi: 10.1136/bmjopen-2016-014112.

41.

Effect of aclidinium bromide on cough and sputum symptoms in moderate-to-severe COPD in three phase III trials.

McGarvey L, Morice AH, Smith JA, Birring SS, Chuecos F, Seoane B, Jarreta D.

BMJ Open Respir Res. 2016 Dec 8;3(1):e000148. doi: 10.1136/bmjresp-2016-000148. eCollection 2016.

42.

Cough frequency monitors: can they discriminate patient from environmental coughs?

Kulnik ST, Williams NM, Kalra L, Moxham J, Birring SS.

J Thorac Dis. 2016 Nov;8(11):3152-3159. doi: 10.21037/jtd.2016.11.02.

43.

Translation and validation of the King's Brief Interstitial Lung Disease (K-BILD) questionnaire in French, Italian, Swedish, and Dutch.

Wapenaar M, Patel AS, Birring SS, Domburg RTV, Bakker EW, Vindigni V, Sköld CM, Cottin V, Vancheri C, Wijsenbeek MS.

Chron Respir Dis. 2017 May;14(2):140-150. doi: 10.1177/1479972316674425. Epub 2016 Dec 26.

44.

Treating acute cough: wet versus dry - have we got the paradigm wrong?

Morice AH, Kantar A, Dicpinigaitis PV, Birring SS, McGarvey LP, Chung KF.

ERJ Open Res. 2015 Oct 23;1(2). pii: 00055-2015. eCollection 2015 Oct.

45.

Physiotherapy, and speech and language therapy intervention for patients with refractory chronic cough: a multicentre randomised control trial.

Chamberlain Mitchell SA, Garrod R, Clark L, Douiri A, Parker SM, Ellis J, Fowler SJ, Ludlow S, Hull JH, Chung KF, Lee KK, Bellas H, Pandyan A, Birring SS.

Thorax. 2017 Feb;72(2):129-136. doi: 10.1136/thoraxjnl-2016-208843. Epub 2016 Sep 28.

PMID:
27682331
46.

[German Validation of the "King's Brief Interstitial Lung Disease (K-Bild) Health Status Questionnaire"].

Kreuter M, Birring SS, Wijsenbeek M, Wapenaar M, Oltmanns U, Costabel U, Bonella F.

Pneumologie. 2016 Nov;70(11):742-746. Epub 2016 Sep 21. German.

PMID:
27652583
47.

Validation of the Polish Version of the Chronic Cough Quality of Life Questionnaire (Leicester Cough Questionnaire).

Dąbrowska M, Krakowiak K, Radlińska O, Rybka A, Grabczak EM, Maskey-Warzęchowska M, Korczyński P, Birring SS, Krenke R.

Adv Clin Exp Med. 2016 Jul-Aug;25(4):649-53. doi: 10.17219/acem/59512.

48.

Cough in idiopathic pulmonary fibrosis.

van Manen MJ, Birring SS, Vancheri C, Cottin V, Renzoni EA, Russell AM, Wijsenbeek MS.

Eur Respir Rev. 2016 Sep;25(141):278-86. doi: 10.1183/16000617.0090-2015. Review.

49.

Gastroesophageal dysmotility is associated with the impairment of cough-specific quality of life in patients with cough variant asthma.

Kanemitsu Y, Niimi A, Matsumoto H, Iwata T, Ito I, Oguma T, Inoue H, Tajiri T, Nagasaki T, Izuhara Y, Petrova G, Birring SS, Mishima M.

Allergol Int. 2016 Jul;65(3):320-6. doi: 10.1016/j.alit.2016.02.014. Epub 2016 Apr 4.

50.

Validation of the King's Sarcoidosis Questionnaire (KSQ) in a Dutch sarcoidosis population.

Van Manen MJ, Wapenaar M, Strookappe B, Drent M, Elfferich M, de Vries J, Gosker HR, Birring SS, Patel AS, van den Toorn L, van den Blink B, Boomars K, Hoitsma E, Wijsenbeek MS.

Sarcoidosis Vasc Diffuse Lung Dis. 2016 Mar 29;33(1):75-82.

PMID:
27055839

Supplemental Content

Loading ...
Support Center